Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18471305

Download in:

View as

General Info

PMID
18471305